STF-118804
99%
- Product Code: 102641
CAS:
894187-61-2
| Molecular Weight: | 461.53 g./mol | Molecular Formula: | C₂₅H₂₃N₃O₄S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD14918065 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
STF-118804 is primarily researched for its potential in cancer therapy. It has shown promise in targeting cancer cells by inhibiting specific pathways that are crucial for their survival and proliferation. This compound is particularly studied for its ability to overcome drug resistance in certain types of cancer, making it a potential candidate for treating cancers that do not respond well to conventional therapies. Researchers are exploring its efficacy in preclinical models to understand its mechanism of action and to evaluate its safety and effectiveness for future clinical applications.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿4,761.00 |
+
-
|
STF-118804
STF-118804 is primarily researched for its potential in cancer therapy. It has shown promise in targeting cancer cells by inhibiting specific pathways that are crucial for their survival and proliferation. This compound is particularly studied for its ability to overcome drug resistance in certain types of cancer, making it a potential candidate for treating cancers that do not respond well to conventional therapies. Researchers are exploring its efficacy in preclinical models to understand its mechanism of action and to evaluate its safety and effectiveness for future clinical applications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :